MIR3118-5: A Drug Target / Disease Biomarker (G100422890)

MIR3118-5: A Drug Target / Disease Biomarker

MIR3118-5 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that are involved in various cellular processes. One of the main functions of MIR3118-5 is to regulate the levels of glucose in the body.

MIR3118-5 is expressed in the brain, where it is involved in the regulation of glucose uptake and storage. It has been shown to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its role in neurodegenerative diseases, MIR3118-5 has also been shown to be involved in various physiological processes that are important for the survival and function of the body. For example, it has been shown to be involved in the regulation of blood pressure, and to play a role in the regulation of inflammation.

MIR3118-5 is also of interest as a potential drug target. The development of neurodegenerative diseases is a major public health burden, and there is a need for new and effective treatments. MIR3118-5 is a potential drug target because it is involved in the regulation of important cellular processes that are involved in the development and progression of these diseases.

In conclusion, MIR3118-5 is a protein that is of interest as a potential drug target. Its involvement in the regulation of glucose uptake and storage, as well as its involvement in the regulation of various physiological processes, makes it a promising target for new and effective treatments for neurodegenerative diseases. Further research is needed to fully understand the role of MIR3118-5 in the development and progression of these diseases, as well as its potential as a drug target.

Protein Name: MicroRNA 3118-5

The "MIR3118-5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3118-5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG